Intended for U.S. healthcare professionals only.
For corporate information, please visit Mallinckrodt.com

Compounding Powders
In This Section

Compounding Powders

Compounding PowdersIn compounding, "powder" refers to a dosage form that exists as fine particles. The formulation may contain only the active drug or may be mixed with other ingredients.

Compounding Powders
Cocaine Hydrochloride USP CII Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information
Codeine Phosphate USP Powder CII Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information
Fentanyl Citrate USP Special CII Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information
Hydrocodone Bitartrate USP Crystals CII Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information
Hydromorphone Hydrochloride USP CII Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information
Meperidine Hydrochloride USP CII Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information
Methadone Hydrochloride USP Powder CII Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information
Methylphenidate Hydrochloride USP CII Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information
Morphine Sulfate USP (Special) CII Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information
Naloxone Hydrochloride USP Dihydrate Standard Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information
Oxycodone Hydrochloride USP (D) CII Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information
Sufentanil Citrate USP CII Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information

Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.© 2025 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc,(in examination under Part 10 of the Companies Act 2014), which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland.

UnitedHealthcare creates and publishes the Machine-Readable Files on behalf of Mallinckrodt. To link to the Machine-Readable Files, please click on the URL provided: transparency-in-coverage.uhc.com.

Resources
Contact Us Terms of Use Cookie Policy Privacy Policy Privacy Choices CCPA Icon